Old Web
English
Sign In
Acemap
>
authorDetail
>
Herman van Besien
Herman van Besien
Cornell University
Immunology
Lymphoma
Molecular biology
Hsp90 inhibitor
PI3K/AKT/mTOR pathway
3
Papers
29
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Targeting Metabolic Vulnerabilities in Primary Effusion Lymphoma Using the Novel Nucleoside Analog 6-Eti
2021
Blood
Jouliana Sadek
Jan Krumsiek
Tuo Zhang
Barbara Coan
Maite Ibáñez de Garayo
Tanner Dalton
Sara Yahyaei
Herman van Besien
Ethel Cesarman
Show All
Source
Cite
Save
Citations (0)
Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma
2017
Molecular Cancer Therapeutics
Lisa Giulino Roth
Herman van Besien
Tanner Dalton
Jennifer Totonchy
Anna Rodina
Tony Taldone
Alexander Bolaender
Hediye Erdjument-Bromage
Jouliana Sadek
Amy Chadburn
Matthew J. Barth
Filemon Dela Cruz
Allison R. Rainey
Andrew L. Kung
Gabriela Chiosis
Ethel Cesarman
Show All
Source
Cite
Save
Citations (29)
Targeting the Hsp90 Oncoproteome in Burkitt Lymphoma
2015
Blood
Lisa Giulino Roth
Herman van Besien
Anna Rodina
Tony Taldone
Hediye Erdjument-Bromage
Matthew J. Barth
Gabriela Chiosis
Ethel Cesarman
Show All
Source
Cite
Save
Citations (0)
1